|
|
High-Content RNAi Phenotypic Screening Unveils the Involvement of Human Ubiquitin-Related Enzymes in Late Cytokinesis
Mikaël Boullé
,
Laurianne Davignon
,
Keïs Nabhane Saïd Halidi
,
Salomé Guez
,
Emilie Giraud
,
et al.
Journal articles
pasteur-04104805v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors
Haitham Hassan
,
Jeanne Chiavaralli
,
Afnan Hassan
,
Loay Bedda
,
Tim Krischuns
,
et al.
Journal articles
hal-03981817v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages
Franck Touret
,
Emilie Giraud
,
Jérôme Bourret
,
Flora Donati
,
Jaouen Tran-Rajau
,
et al.
Journal articles
pasteur-04072734v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Jiří Zahradník
,
Shir Marciano
,
Maya Shemesh
,
Eyal Zoler
,
Daniel Harari
,
et al.
Journal articles
pasteur-03321160v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
K.Y. Chen
,
T. Krischuns
,
L. Ortega Varga
,
E. Harigua-Souiai
,
S. Paisant
,
et al.
Journal articles
pasteur-03840856v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Identification of antiviral compounds against equid herpesvirus‐1 using Real‐Time Cell Analysis: screening of 2,891 molecules
Côme Thieulent
,
Erika Hue
,
Gabrielle Sutton
,
Christine Fortier
,
Patrick Dallemagne
,
et al.
Conference papers
hal-03405801v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Cyril Planchais
,
Ignacio Fernández
,
Timothée Bruel
,
Guilherme Dias de Melo
,
Matthieu Prot
,
et al.
Journal articles
hal-03697587v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|